Jacobs Solutions J

Reference table

1. What it is

Jacobs Solutions (NYSE: J) is a ~$12B-revenue global engineering, design, consulting and program-management firm headquartered in Dallas, founded in 1947, ~43,000 employees. It plans, designs, engineers and manages the delivery of infrastructure and advanced-facility projects — and, through PA Consulting, does high-end management/tech consulting. Fiscal year ends late September.

Crucially, today's Jacobs is a very different company from three years ago. It has been reshaped by portfolio surgery: the cyclical/government-services businesses (Critical Mission Solutions, Divergent Solutions — now Amentum) were separated in late 2024, and Jacobs re-segmented into two continuing pieces. This is why the historical segment and revenue lines jump around in the data, and why trailing GAAP EPS is not a clean read.

Revenue mix (FY2025, from filings):

• By segment: Infrastructure & Advanced Facilities $10.76B (89%) · PA Consulting $1.27B (11%). I&AF is the growth engine (data centers, semiconductors, water, energy & power, transportation); PA Consulting is a higher-margin consulting arm now fully owned.
• By geography (continuing-ops detail): United States $7.42B (~63%) · Europe $2.87B (~24%) · Middle East & Africa $0.60B · Australia/NZ $0.57B · Canada $0.25B · India $0.18B · Asia $0.14B. US-weighted but meaningfully international.

The strategic story management keeps hammering: Jacobs sits at "a central position in the build-out of AI and related infrastructure" — i.e. the picks-and-shovels engineering firm for the data-center and semiconductor capex super-cycle, plus secular water and grid spend.

2. The expert thesis — no panel coverage (traceable)

There is no expert coverage of Jacobs Solutions in the Synthos knowledge base. total_claims = 0; zero net-bullish voices, zero cautionary voices, zero traceable claim_ids. Unlike our conviction-track names (e.g. Lilly, with 13 net-bullish voices and 251 reconciled claims), J did not enter through expert conviction. It enters on the quant/fundamental screen.

Accordingly, every judgment in this note is fundamentals- and quant-driven — built from FMP financials, live analyst estimates, and management's own SEC-filed guidance (§9, half-weighted). We will not manufacture conviction we do not have. The Street, for what it is worth as context, is constructive: 24 Buy / 14 Hold / 0 Sell, consensus target $156.13. But that is sell-side context, not the independent expert signal Synthos exists to surface — treat this as a data-and-guidance call.

3. Synthos scores & the Bull / Base / Bear cases

Three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):

The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities; the cases bound the range and the scores summarize them. All EPS figures are adjusted (the GAAP line is noise this year).

Synthos fair value = the base case, ~$150 (+17%), with the full $95–$175 span as the honest range. This sits just below the Street's $156 consensus — we broadly agree with the sell side here but discount slightly for cyclicality and the unproven durability of the AI-infrastructure order flow. This is a tracked call — the Forecaster Scorecard grades it once it matures.

4. Exponential Potential

Synthos separates compounders (durable steady growth) from exponentials (accelerating multi-baggers). Jacobs is a solid compounder, not an exponential:

• Forward growth: adjusted-EPS CAGR FY26E→FY29E ~16.4% ($7.24 → $11.43); revenue CAGR is lower (revenue is partly a pass-through of subcontract cost — adjusted net revenue growth is the cleaner ~8–10.5% guided figure).
• Acceleration (2nd derivative) is roughly flat, not positive. Adjusted EPS is guided to grow ~20% in FY26 then settle to mid-teens (FY27 +14%, FY28 +13%, FY29 +22% on 1–3 analysts). Backlog is the tell — record $27B and growing 22% y/y — but this is a broadening tailwind, not a self-reinforcing acceleration. Per our flagship philosophy we prize forward acceleration; J shows durability, not lift-off.
• Room to run: at $15B market cap the name is far from a law-of-large-numbers ceiling, and the addressable market (global infrastructure + AI/data-center + water + grid capex) is enormous. So room is not the binding constraint —
• …the binding constraint is the delivery model. Engineering/consulting scales with billable people. More revenue mostly means more hires, so incremental margins are bounded and the growth slope is structurally capped. That is why a genuinely large TAM still only earns a 4/10: the tailwind is real, the multiplier is not.

Exponential Potential: Modest. Own J for a steady mid-teens earnings compounder levered to a real capex super-cycle — not for a fast multibagger. This framing is why it belongs in the satellite/tactical sleeve, not the core.

5. Financials (real numbers — FMP annual/quarterly + guidance)

• Revenue: FY25 $12.03B, +4.6% (FY24 $11.50B; FY23 $10.85B). Gross revenue growth understates the story — much of it is pass-through subcontractor cost; management steers on adjusted net revenue (+8.8% y/y in Q2 FY26).
• Backlog (the leading indicator): record $27.0B, +21.7% y/y, TTM book-to-bill 1.4× — i.e. winning work faster than burning it. This is the single most important forward tell for an E&C firm.
• Margins: GAAP gross ~23.4% TTM; adjusted EBITDA margin guided 14.6–14.9% (of adjusted net revenue) and expanding. Net margin is thin (~3% TTM GAAP) and distorted this year.
• The GAAP-vs-adjusted gap (read this carefully): Q2 FY26 posted a GAAP loss (−$0.32 EPS) while adjusted EPS was +$1.75 (+22.4% y/y). The loss was driven by PA Consulting acquisition transaction costs, not operations. Trailing GAAP EPS (~$3.26 TTM) and the resulting 39× P/E are misleading; the ~17.7× forward-adjusted multiple is the honest lens.
• Cash flow: FY25 operating CF $687M, capex only −$79M (asset-light), FCF $607M; management guides FY26 adjusted FCF margin 7.0–8.5%. Solid cash conversion.
• Balance sheet: net debt ~$1.47B. Reported net-debt/EBITDA ~3.5× is distorted by the depressed TTM GAAP EBITDA (the PA charge pushed Q2 EBITDA negative); against ~$1.7–1.8B of adjusted EBITDA, leverage is a manageable ~1.5–2×. Current ratio 1.43×. Investment-grade posture; ~$472M of buybacks YTD and a dividend raised 12.5%.

6. Valuation — priced in or room?

On trailing GAAP J looks expensive (39× EPS) — but that number is corrupted by the PA transaction charge and post-spin noise, so ignore it. On forward adjusted earnings, which is how management and the Street underwrite this business, the multiple is reasonable: ~17.7× FY26E ($7.24) → 15.5× FY27E ($8.27) → 13.7× FY28E ($9.36) → 11.2× FY29E ($11.43). EV/EBITDA ~20× TTM (again inflated by the charge), EV/sales just 1.4×. A ~17–18× forward multiple on a mid-teens compounder with a record backlog is fair, arguably slightly cheap — the classic "growth-at-a-reasonable-price" zone, especially with the stock 22% off its high. Street targets (context): consensus $156.13, high $175, low $137 — our $150 base is a touch below consensus because we haircut for cyclicality and AI-capex durability risk. Not a deep-value screen; a reasonably-priced steady grower in a beaten-down chart.

7. Technicals (from the FMP tech block)

• Trend: mixed / basing. $127.89 sits above the 50-DMA ($121.89) but below the 200-DMA ($135.94) — the 50 under the 200 is a lingering downtrend posture, though price reclaiming the 50-DMA hints at a base.
• Location: −22.2% off the 52-week high ($164.44), +19.2% off the 52-week low ($107.27); max drawdown from peak −22.2%. A name that has corrected hard and is trying to stabilize.
• Momentum: RSI(14) 53 — neutral, neither oversold nor overbought; MACD mildly positive (+1.18).
• Relative strength (the honest tell): J is −3.6% over 12 months while SPY is +20.6% and QQQ +30.3% (−4.1% 3-mo vs SPY +13.7%). It has badly lagged — this is a contrarian/mean-reversion setup, not a momentum-leadership one.
• Read: technicals argue for patience/scaling in. The reclaim of the 50-DMA is constructive, but a decisive move back above the 200-DMA (~$136) would confirm the turn. No urgency; accumulate on weakness.

8. Moat & competitive position

Jacobs' moat is reputation, scale, security clearances, and multi-year client relationships rather than a structural monopoly. Engineering News-Record ranks it the #1 Design Firm and #1 in Manufacturing — real brand equity in a business where clients de-risk mega-projects by hiring proven names. Barriers: technical depth across specialized verticals (semiconductors, water, nuclear/energy), a global delivery footprint, and a $27B backlog that locks in multi-year revenue. But it is a competitive, bid-based services industry — switching costs are moderate, pricing is disciplined by rivals, and margins are structurally capped by the labor model.

Peer set (FMP-supplied, market cap): the FMP peer list here is an imperfect algorithmic match — it skews to tech/software (Gartner $9.1B, SS&C $15.8B, Trimble $12.4B, Tyler Technologies $13.4B, CGI $14.4B, Nutanix $13.9B, GoDaddy $11.7B, Gen Digital $16.1B, Logitech $13.5B, Corpay $23.0B) rather than J's true engineering-and-construction comps (AECOM, WSP, Fluor, Stantec, Tetra Tech). Read the peer table with caution: on a true E&C basis Jacobs is a scale leader; against the software-heavy FMP list its ~17–18× forward multiple and mid-teens growth look average-to-cheap, but the comparison is apples-to-oranges.

9. Management, capital allocation & guidance

• Capital allocation: balanced and shareholder-friendly — $472M of buybacks YTD, a 12.5% dividend raise, completion of the PA Consulting buy-in, and active optimization of the capital structure (lower weighted-average interest rate). Asset-light model (capex <1% of revenue) throws off real FCF.
• Insider activity (a genuine positive): the sampled window shows open-market purchases by insiders, not just sales — CEO/Chair Robert Pragada bought 3,601 shares at $111.09 (2026-05-15) and director Manuel Fernandez bought 253 shares at $112.56 (2026-05-13). Insiders buying near the lows is a modest confidence signal; the only dispositions are routine tax-withholding (F-InKind) and equity awards.
• Management's own guidance (half-weighted — their self-interested words): The 2026-05-05 Q2 FY26 8-K earnings release is a real, substantive release (revenue, backlog, explicit outlook). Management raised FY26 guidance for the second consecutive quarter: adjusted net revenue growth 8.0–10.5% (up from 6.5–10.0%), adjusted EBITDA margin 14.6–14.9% (up from 14.4–14.7%), adjusted EPS $7.10–$7.35 (up from $6.95–$7.30), adjusted FCF margin 7.0–8.5%. CFO stated they are "on track to reach or exceed all of our FY29 targets," crediting "accelerating top-line growth from our central position in the build-out of AI and related infrastructure." Weight this as management talking its own book — but the twice-raised guide plus a record backlog is a credible, corroborated signal, not just spin.

10. Catalysts & what to watch

• Next earnings: 2026-08-04 (Q3 FY26; Street EPS ~$1.84). The key lines: backlog / book-to-bill (is the AI-infrastructure order flow still compounding?) and adjusted EBITDA margin (synergy delivery).
• Backlog trajectory: any deceleration below ~1.2× book-to-bill would challenge the thesis.
• AI / data-center & semiconductor capex: J's growth is levered to hyperscaler and chip-fab construction — watch for capex-digestion signals from that ecosystem.
• PA Consulting integration: $20M+ synergy delivery within 24 months; margin follow-through.
• Government budgets: transportation, water, and defense funding shifts (US and international).

Thesis tripwires (what would change the call): two consecutive quarters of backlog / book-to-bill decline; a cut to FY26/FY29 adjusted guidance; adjusted EBITDA margin slipping below ~14%; or a decisive technical breakdown back under the 52-week low.

11. Key risks

• Cyclicality / end-market demand (structural): engineering demand tracks construction, capex cycles, and government budgets — a recession or an AI-capex pause hits the order book.
• AI-infrastructure concentration: the growth narrative leans heavily on the data-center/semiconductor build-out; a capex digestion phase would remove the marquee tailwind.
• Messy GAAP / integration: PA Consulting transaction charges muddy reported earnings and carry integration risk; investors relying on GAAP screens may misprice it either way.
• Thin margins / labor model: a people-based services business with mid-single-digit net margins and wage inflation exposure — limited operating leverage.
• Leverage optics: reported net-debt/EBITDA ~3.5× (distortion aside) plus goodwill/intangibles ~45% of assets leave less cushion than a fortress balance sheet.
• No independent expert corroboration: the bull case rests on filings, guidance, and the sell side — Synthos has zero KB conviction here, so this is a lower-confidence call by construction.

12. Verdict, position sizing & monitoring

Buy — Tactical. Jacobs is a fairly-to-attractively priced (~17–18× forward adjusted EPS), asset-light engineering compounder with a record $27B backlog (1.4× book-to-bill), twice-raised FY26 guidance, insider buying near the lows, and a genuine secular tailwind in AI-infrastructure, semiconductor, water and grid build-out. The chart is beaten down (−22% off the high, lagging the market badly) — a contrarian/mean-reversion setup with real fundamental support. What holds it back from Core: cyclical, government-linked end-markets; a labor-scaled model that caps the growth slope; messy post-spin GAAP; and — importantly — no expert conviction in the Synthos KB. This is a data-and-guidance call, not a high-conviction one.

• Sizing: satellite / tactical, ~2–3% — an opportunistic re-rating candidate, scaled in on weakness (the stock's own lag and the below-200-DMA posture argue against a single lump). A reclaim of the 200-DMA (~$136) would justify adding.
• Monitoring: re-underwrite on the §10 tripwires; formal re-score each earnings print, with backlog/book-to-bill as the primary tell. This verdict is logged as a tracked Synthos call as of 2026-07-03 at $127.89.
• Single biggest risk: a cyclical or AI-capex-digestion stall that freezes the record backlog — the whole thesis rides on that order flow continuing to compound.

Provenance & disclosures

• Traceability: 0 KB claims, breadth 0 — J has no expert coverage in the Synthos knowledge base. This note is explicitly fundamentals- and quant-driven; no claim_ids are cited because none exist. Fabricated conviction is structurally impossible (claim-ID reconciliation), and we state the absence of coverage plainly rather than dress up sell-side notes as conviction.
• Data as-of: fundamentals 2026-03-27 (Q2 FY26) · estimates & prices 2026-07-02/03 · management guidance from the 2026-05-05 SEC 8-K (Item 2.02). Forward figures are analyst consensus (FMP) or management guidance, labeled as estimates.
• Management caveat: FY26 guidance is management's own book, half-weighted by design; corroborated here by a record backlog and twice-raised outlook.
• GAAP caveat: trailing GAAP EPS and the derived P/E, EV/EBITDA and net-debt/EBITDA are distorted by PA Consulting transaction charges and the Amentum separation; adjusted metrics are used where noted.
• Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
• Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").